SEARCH FIRM NEWS
This month, the U.S. Food and Drug Administration (FDA) issued a new broad-reaching guidance document for clinical investigation sponsors, clinical investigators, institutional review boards (IRB), contract research organizations (CRO), and other interested parties on the use of electronic systems, electronic records, and electronic signatures in clinical investigations. See FDA guidance document entitled “Electronic Systems, Electronic […]
The FTC has finalized its updated Negative Option Rule, also known as the “Click to Cancel” Rule.
Ivan Wasserman discussed a new bill before Congress that would change how companies bring new ingredients to market in the Oct. 4 issue of SupplySide Supplement Journal.
Last week, California Governor Gavin Newsom signed Assembly Bill 2863, which amended California’s automatic renewal/continuous service law. There are some important changes to the law that go into effect on July 1, 2025.
On Thursday, Sept. 12, New Jersey’s Governor signed into law legislation that prohibits the sale or distribution of a product intended for human consumption that contains THC in any detectable amount to those under 21 years of age. The bill also defines “hemp product” as a product with not more than 0.5 mg of total […]
On Sept. 6, 2024, the California Dept. of Public Health issued a notice of intent to file an emergency regulatory action that would prohibit the manufacture, warehousing, distribution, offer, advertising, marketing, or sale of any hemp product intended for human consumption containing “detectable” THC, including foods, beverages, and dietary supplements.
Char Pagar has joined the firm’s Washington, DC office as Counsel in the firm’s Regulatory Group. She was formerly lead e-commerce counsel at Walmart, senior marketing counsel at Sears, and an attorney in the Bureau of Consumer Protection at the Federal Trade Commission.
Senior Editor Hank Schultz, Natural Products Insider, turned to Bob Durkin for perspective on a new bill that would create two new agencies: the Federal Drug Administration and the Federal Food Administration.
Ivan Wasserman commented on Health and Human Services Secretary Robert F. Kennedy, Jr.’s directing acting FDA Commissioner to explore eliminating the self-affirmed GRAS pathway for ingredients for NutraIngredients USA.
see all news >